Search

everythinglearnresearchcommunity

for

Search:↓

The main causes of diffuse hair loss in women are telogen effluvium and androgenetic alopecia, often related to stress and iron deficiency.

Modern skin cancer treatments can cause skin side effects and hair loss, affecting patients' quality of life.

Plant-based chemicals may help hair growth and prevent hair loss but need more research to compete with current treatments.

Immune checkpoint inhibitors used in cancer therapy can cause hair loss, and understanding this can help manage the side effect.

Only minoxidil and finasteride are FDA-approved for hair loss, with other treatments available but less effective or with side effects.

T-cell reconstitution after thymus transplantation can cause hair whitening and loss.

Cancer treatments can cause hair loss, but it is often reversible and can be managed with scalp cooling and support.

Cancer treatments targeting specific cells and the immune system can cause skin, mouth, hair, and nail problems, affecting patients' quality of life and treatment adherence.

Genetic screening is crucial for accurately diagnosing APS-1 due to its varied symptoms.

Cancer treatments often cause hair disorders, significantly affecting patients' quality of life, and better management methods are needed.

A new mutation in the STING protein causes a range of symptoms and its severity may be affected by other genetic variations; treatment with a specific inhibitor showed improvement in one patient.

Immune checkpoint inhibitors can cause skin issues but are linked to better cancer outcomes.

The S250C variant in a gene may cause autoimmunity and immunodeficiency by impairing protein function.

The document concludes that understanding and managing hair loss in cancer patients is important, and more research is needed for better treatments.

New cancer treatments are less harmful to hair but can still cause hair loss, color, shape, and growth changes.

The microenvironment, especially mechanical forces, plays a crucial role in hair growth and could lead to new treatments for hair loss.

People with late-stage HIV-1 often experience a specific type of hair loss linked to multiple factors, including nutritional issues and immune responses.

Low iron levels are linked to hair loss in women.

Eyelashes protect the eyes, but more research is needed to understand how.

Some drugs can cause changes to your hair.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

Some treatments can help with a hair loss condition called alopecia areata, but none ensure lasting results; choices depend on the person, with JAK inhibitors showing promise for severe cases.

No systemic treatment for alopecia areata has strong evidence of effectiveness.

Tofacitinib helped regrow hair in patients with alopecia, with few side effects.

Medium-dose prednisolone pulse therapy is effective and safe for multifocal alopecia areata but not for more severe forms.

Some people with severe, long-lasting baldness responded well to a specific combination treatment.

Early onset, severe types, nail changes, family history, and body hair loss worsen alopecia areata prognosis; sticking to treatment helps.

Herbal lotions are effective for severe hair loss, with a 64.8% success rate, but relapse is common and long-term management requires allergen control and possible corticosteroid use.

A man with severe hair loss regrew hair after hormone treatment.

Fractional and excimer lasers effectively treat various types of alopecia and promote hair growth.